Literature DB >> 25233157

Critical-sized defect in the tibia: is it critical? Results from the SPRINT trial.

David W Sanders1, Mohit Bhandari, Gordon Guyatt, Diane Heels-Ansdell, Emil H Schemitsch, Marc Swiontkowski, Paul Tornetta, Stephen Walter.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether the SPRINT definition of a "critical-sized defect" (fracture gap at least 1 cm in length and involving over 50% of the cortical diameter) was accurate, to discern which factors predict reoperation in patients with these defects, and to compare the patient-based outcomes of these patients with patients without a critical defect.
DESIGN: Therapeutic Cohort Study.
SETTING: Level 1 and level 2 trauma centers. PATIENTS: Thirty-seven patients in the SPRINT trial with a critical-sized defect participated. We evaluated these patients for planned and unplanned secondary intervention to gain union. Additionally, we evaluated which other factors predicted the need for reoperation. Finally, the 37 patients with a critical defect were compared with the larger cohort of patients without a defect with respect to demographics, mechanism of injury, fracture characteristics, and patient-based outcome. INTERVENTION: Revision surgery for tibial nonunion.
RESULTS: Of the 37 patients with a large fracture gap, 7 patients had a planned secondary procedure. Of the remaining 30 patients in whom the attending surgeon adopted a "watch and wait" strategy, 14 patients (47%) never required additional surgery to gain union. Additional surgery to gain union was less likely in patients treated with a reamed nail (P = 0.04) and in female patients (P = 0.04). Patients with a critical-sized defect were more likely to have a high-energy mechanism of injury (P = 0.001), AO-OTA fracture type 42 B or C (P < 0.001), and location involving the middle third of the tibia (P = 0.02). The 12-month SF-36 physical component summary score in patients with a critical-sized defect was 38.2 ± 10.5 (mean ± SD) compared with 43.3 ± 10.7 in those without a critical defect (P = 0.02, difference = 5.2, 95% confidence interval = 0.8-9.6).
CONCLUSIONS: Tibial diaphyseal defects of >1 cm and >50% cortical circumference healed without additional surgery in 47% of cases. This definition of a critical-sized defect is not "critical." However, as compared with the overall cohort of tibial fractures, patients with these bone defects had a higher rate of reoperation and worse patient-based outcomes. Further investigation is required to determine which factors predict union in this challenging fracture to avoid unnecessary secondary surgery. LEVEL OF EVIDENCE: Prognostic level I. See instructions for authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2014        PMID: 25233157     DOI: 10.1097/BOT.0000000000000194

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  14 in total

1.  Decorating 3D Printed Scaffolds with Electrospun Nanofiber Segments for Tissue Engineering.

Authors:  Ruiquan Li; Alec McCarthy; Yu Shrike Zhang; Jingwei Xie
Journal:  Adv Biosyst       Date:  2019-11-04

2.  Novel 3D Hybrid Nanofiber Aerogels Coupled with BMP-2 Peptides for Cranial Bone Regeneration.

Authors:  Lin Weng; Sunil Kumar Boda; Hongjun Wang; Matthew J Teusink; Franklin D Shuler; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2018-03-02       Impact factor: 9.933

3.  Will My Tibial Fracture Heal? Predicting Nonunion at the Time of Definitive Fixation Based on Commonly Available Variables.

Authors:  Kevin O'Halloran; Max Coale; Timothy Costales; Timothy Zerhusen; Renan C Castillo; Jason W Nascone; Robert V O'Toole
Journal:  Clin Orthop Relat Res       Date:  2016-06       Impact factor: 4.176

4.  3D Hybrid Nanofiber Aerogels Combining with Nanoparticles Made of a Biocleavable and Targeting Polycation and MiR-26a for Bone Repair.

Authors:  Ruiquan Li; Hongjun Wang; Johnson V John; Haiqing Song; Matthew J Teusink; Jingwei Xie
Journal:  Adv Funct Mater       Date:  2020-09-09       Impact factor: 18.808

5.  Three-dimensional printed poly (L-lactide) and hydroxyapatite composite for reconstruction of critical bone defect in rabbits.

Authors:  Bruno Watanabe Minto; Arícia Gomes Sprada; José Aloizio Gonçalves Neto; Brenda Mendonça de Alcântara; Thiago André Salvitti de Sá Rocha; Ana Carolina Valentim Hespanha; Carolina Quarterone; Maressa da Rocha Sartori; Alessandre Hataka; Ricardo Andres Ramirez Uscategui; Luis Gustavo Gosuen Gonçalves Dias
Journal:  Acta Cir Bras       Date:  2021-05-21       Impact factor: 1.388

Review 6.  Systematic Review of the Preclinical Technology Readiness of Orthopedic Gene Therapy and Outlook for Clinical Translation.

Authors:  Piers Wilkinson; Ilya Y Bozo; Thomas Braxton; Peter Just; Elena Jones; Roman V Deev; Peter V Giannoudis; Georg A Feichtinger
Journal:  Front Bioeng Biotechnol       Date:  2021-03-17

7.  Managing bone loss in open fractures.

Authors:  Andrew Adamczyk; Bradley Meulenkamp; Geoffrey Wilken; Steven Papp
Journal:  OTA Int       Date:  2020-03-23

8.  Osteocalcin biomarker level evaluation on fracture healing with bone defect after stromal vascular fraction application in murine model.

Authors:  Respati S Dradjat; Panji Sananta; Rizqi Daniar Rosandi; Lasa Dhakka Siahaan
Journal:  Ann Med Surg (Lond)       Date:  2021-11-02

9.  Nano-Hydroxyapatite Bone Scaffolds with Different Porous Structures Processed by Digital Light Processing 3D Printing.

Authors:  Haowen Liang; Yue Wang; Shangsi Chen; Yang Liu; Zhengbai Liu; Jiaming Bai
Journal:  Int J Bioprint       Date:  2022-01-17

Review 10.  Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysis.

Authors:  H Bezstarosti; W J Metsemakers; E M M van Lieshout; L W Voskamp; K Kortram; M A McNally; L C Marais; M H J Verhofstad
Journal:  Arch Orthop Trauma Surg       Date:  2020-08-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.